Kraig Biocraft Laboratories releases a statement regarding Spider Silk Industry

2018-04-26T15:14:24+00:00 Apr. 18, 2018 8:15AM EST|

As the Company prepares for commercialization of its engineered spider silk, Kraig Labs shares information on the developing industry.

ANN ARBOR, Mich., –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, releases the following statement regarding developments in the growing Spider Silk Industry.

Spider silk’s toughness is said to be 10 times greater than steel and some silks are nearly as elastic as rubber. According to some studies, spider silks can be two to three times tougher than even Kevlar, which explains why so many researchers have targeted this fiber for protective clothing and body armor applications, as well as other potential military applications including technical undergarments and more practical ropes.

Numerous scientific studies have highlighted spider silk’s many intrinsic qualities and why it may be the ideal fiber for a slew of applications. For example, spider silk’s maximal resilience, or ability to absorb energy, makes it one of the sturdiest materials on a weight-to-weight basis. These properties could make spider silk the foundation for many lightweight products, including air bags, seat belts, flexible bridge suspension cables, sports helmets and motor vehicle panels.

Additionally, studies have shown spider silk to be antimicrobial, biocompatible, hypoallergenic and totally biodegradable. Spider silk is a biomaterial that could be the platform on which to develop many medical technologies, like better bandages, elastic ligaments, and artificial tendons and even biodegradable water bottles.

Concurrent to Kraig Labs positioning for commercial production of its advanced fibers, many independent scientific studies have shown great promise in a vast array of potential spider silk applications. The Company would like to congratulate all efforts that advance spider silk technologies. A few recent examples of that work are provided below. Each of these reports is entirely unaffiliated with Kraig Labs, and we therefore have not and cannot authenticate any specific conclusions.

As noted in the linked report, just the chronic wounds, such as bedsores in hospitalized patients, afflict 6.5 million in the United States for an estimated $25 billion annually. The Company believes that the various scientific discoveries in the spider silk space were instrumental in seeing over $300 million in funding flow into spider silk platform development over the past few years. One of the Company’s current competitors is approaching $196 million in aggregate funding, including $106 million in 2017, potentially valuing that pre-production technology at more than $1 billion dollars, when applying a commonly used valuation formula.

http://www.kblbinvestors.com/new-breakthroughs/

“As Kraig Labs prepares to transition into commercial production, we plan to expand our R&D focus and, given the tremendous interest in spider silk, we believe that we will have many great opportunities to grow newly discovered application into new business lines with strong growth potential. As we initiate a process to explore further scientific alliances our objective is to help maximize the future value of Kraig Labs,”

- stated Kim Thompson, Kraig Labs’ CEO and Founder.

Industrial applications may include flexible bridge suspension cables, better fishing nets and unrippable paper. Spider silk’s well-balanced combination of strength and elasticity may even be combined with graphene to create the next generation of metamaterials.

Under funding from the US Army Research Office and the National Science Foundation professor Xinwei Wang at Iowa State University published a paper on Spider silks ability to conduct heat as well or better than most materials, including very good conductors such as silicon, aluminum and pure iron. That discovery reportedly "opens a door for soft materials to be another option for thermal conductivity tuning," as stated by professor Wang in the above reference publication. This may inspire better semiconductors and lead to the creation of flexible, heat-dissipating parts for electronics, microchips, better clothes for hot weather, bandages that don't trap heat and many other everyday applications.

By designing a high performance fiber, based on a proven efficient and ecologically friendly production platform, the Company’s objective is to target a broad cross section of applications in the $160 billion (projected) technical fibers market and the budding smart textile markets. The Company intends to also target the mundane markets, like active wear and the $5 billion raw silk fibers market, which have tighter pricing elasticity.

“It’s very exciting to think that we may be positioned to focus our efforts and resources on participating in advancing some of the many researchers who approach us to employ our fibers for various potential mechanical applications and we’re looking forward to collaborations that could open a new realm of possibilities for our technology,”

- said Jon Rice, Kraig Labs’ COO.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com

Connect with 24/7 Market News on social media:
https://twitter.com/247MarketNewsHQ
https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.

DISCLAIMER:

24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

24/7MN has covered Kraig Biocraft Laboratories, Inc. in the past and owns shares. You may view this as a conflict of interest. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. 24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

For further information on 24/7 Market News, please go to www.247marketnews.com

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MSC undertakes no obligation to update such statements

CONTACT:

24/7 Market News
Editor@247marketnews.com

Send this to a friend

Hi, this may be interesting you: ! This is the link: https://www.247marketnews.com/company/kraig-biocraft-laboratories-inc/